SENISCA
Allan Weiner has a diverse work experience spanning various industries and roles. Allan currently serves as a Non Executive Director at SENISCA since 2021. Prior to this, they worked as an Advisor at malluccilondon starting in 2018. From 2013, Allan worked as a Consultant and Investor as an Independent Advisor. Allan also served as the European Managing Director at MedicX Limited from 2010 to 2012 and as an Executive Director at CareCapital Ltd from 2004 to 2010. Earlier in their career, Allan held positions such as CEO at Euroclinics Ltd in 2002, Principal at Corven Consulting & Ventures in 2002, and Marketing & Sales Director, UK at Medmojo UK in 2001. Allan also worked as an Investment Director at Speed Ventures from 1999 to 2001. Allan's career began at Roland Berger Strategy Consultants where they held roles as a Project Manager, Associate, and Analyst from 1991 to 1998.
Allan Weiner earned a Master of Science degree in Business Administration and Economics from the Stockholm School of Economics, which they attended from 1986 to 1990. In addition, they obtained a Master of Science degree in Business and Economics from Università Bocconi in 1988. Allan also holds a certification as a CF23 Corporate Finance Adviser from the Financial Conduct Authority, which they obtained in June 2002.
This person is not in any teams
SENISCA
Senisca is a biotech start-up. They propose to create a new generation of oligonucleotide-based interventions to rewind the clock in old cells and target diseases and cosmetic signs of aging. They provide molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence.